Aditya Birla Sun Life Pharma and Healthcare Fund
Aditya Birla Sun Life Mutual Fund · FM: Dhaval Shah · INF209KB1O25 · Direct
NAV ₹40.89 AUM ₹1011 Cr as of 22 Sep 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:27 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.6% | +0.3% | +7.1% | +21.9% | +18.6% | +22.6% | +14.5% | 21/234 | 1.05% |
Equity allocation
97.86%
Non-equity allocation (combined)
2.14%
All Equity Holdings (38) latest available
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 122.2 | 12.09% | — |
| 2 | Apollo Hospitals Enterprise Ltd | 73.7 | 7.30% | — |
| 3 | J.B. Chemicals & Pharmaceuticals Ltd | 47.6 | 4.71% | — |
| 4 | Torrent Pharmaceuticals Ltd | 47.3 | 4.68% | — |
| 5 | Aurobindo Pharma Ltd | 46.0 | 4.55% | — |
| 6 | Ajanta Pharma Ltd | 44.3 | 4.38% | — |
| 7 | Mankind Pharma Ltd | 39.6 | 3.92% | — |
| 8 | Lupin Ltd | 37.8 | 3.74% | — |
| 9 | Sai Life Sciences Ltd | 35.4 | 3.50% | — |
| 10 | Abbott India Ltd | 32.9 | 3.26% | — |
| 11 | Emcure Pharmaceuticals Ltd | 32.6 | 3.23% | — |
| 12 | Fortis Healthcare Ltd | 32.4 | 3.21% | — |
| 13 | Cipla Ltd | 29.6 | 2.93% | — |
| 14 | Ipca Laboratories Ltd | 25.8 | 2.55% | — |
| 15 | Gland Pharma Ltd | 25.1 | 2.48% | — |
| 16 | Shilpa Medicare Ltd | 24.4 | 2.41% | — |
| 17 | Corona Remedies Ltd | 23.0 | 2.28% | — |
| 18 | Procter & Gamble Health Ltd | 22.3 | 2.20% | — |
| 19 | Alkem Laboratories Ltd | 19.5 | 1.93% | — |
| 20 | Thyrocare Technologies Ltd | 19.5 | 1.93% | — |
| 21 | Jupiter Life Line Hospitals Ltd | 18.7 | 1.85% | — |
| 22 | Divi's Laboratories Ltd | 17.1 | 1.69% | — |
| 23 | Dr. Lal PathLabs Ltd | 16.1 | 1.59% | — |
| 24 | Metropolis Healthcare Ltd | 14.5 | 1.44% | — |
| 25 | Sanofi Consumer Healthcare India Ltd | 14.5 | 1.44% | — |
| 26 | Dr Reddy's Laboratories Ltd | 13.4 | 1.33% | — |
| 27 | Pfizer Ltd | 12.5 | 1.23% | — |
| 28 | Biocon Ltd | 11.4 | 1.12% | — |
| 29 | Anthem Biosciences Ltd | 10.9 | 1.08% | — |
| 30 | Piramal Pharma Ltd | 10.7 | 1.06% | — |
| 31 | Vijaya Diagnostic Centre Ltd | 10.6 | 1.05% | — |
| 32 | Medi Assist Healthcare Services Ltd | 9.6 | 0.95% | — |
| 33 | Suraksha Diagnostic Ltd | 9.1 | 0.90% | — |
| 34 | Vinati Organics Ltd | 8.6 | 0.85% | — |
| 35 | Syngene International Ltd | 8.3 | 0.82% | — |
| 36 | GlaxoSmithKline Pharmaceuticals Ltd | 7.9 | 0.79% | — |
| 37 | Max Healthcare Institute Ltd Ordinary Shares | 7.9 | 0.78% | — |
| 38 | Jubilant Pharmova Ltd | 6.1 | 0.61% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.